Enzyme replacement therapy and beyond: in memoriam Roscoe O. Brady, M.D. (1923-2016)

Lysosomal storage disorders are strong candidates for the development of specific innovative therapies. The discovery of enzyme deficiencies is an important milestone in understanding the underlying cause of disease. Being able to replace the first missing enzyme in a lysosomal storage required thre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Ries, Markus (VerfasserIn)
Dokumenttyp: Article (Journal) Festschrift
Sprache:Englisch
Veröffentlicht: 17 March 2017
In: Journal of inherited metabolic disease
Year: 2017, Jahrgang: 40, Heft: 3, Pages: 343-356
ISSN:1573-2665
DOI:10.1007/s10545-017-0032-8
Schlagworte:
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s10545-017-0032-8
Verlag, Volltext: https://link.springer.com/article/10.1007/s10545-017-0032-8
Volltext
Verfasserangaben:Markus Ries

MARC

LEADER 00000caa a2200000 c 4500
001 1576784703
003 DE-627
005 20220814172831.0
007 cr uuu---uuuuu
008 180622s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10545-017-0032-8  |2 doi 
035 |a (DE-627)1576784703 
035 |a (DE-576)506784703 
035 |a (DE-599)BSZ506784703 
035 |a (OCoLC)1341012288 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ries, Markus  |d 1971-  |e VerfasserIn  |0 (DE-588)136385338  |0 (DE-627)582068479  |0 (DE-576)300993358  |4 aut 
245 1 0 |a Enzyme replacement therapy and beyond  |b in memoriam Roscoe O. Brady, M.D. (1923-2016)  |c Markus Ries 
264 1 |c 17 March 2017 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First online: 17 March 2017 
500 |a Gesehen am 22.06.2018 
520 |a Lysosomal storage disorders are strong candidates for the development of specific innovative therapies. The discovery of enzyme deficiencies is an important milestone in understanding the underlying cause of disease. Being able to replace the first missing enzyme in a lysosomal storage required three decades of dedicated research. Successful drug development for lysosomal storage disorders was fostered by the U.S. Orphan Drug Act. Various optimization strategies have the potential to overcome the current limitations of enzyme replacement therapies. In addition, substrate reduction therapies are an alternative approach to treat lysosomal storage disorders, chemical chaperones enhance residual enzyme activity, and small molecules can facilitate substrate transport through subcellular compartments. Bone-marrow derived multipotent stem cells and gene therapies have received FDA orphan drug designation status. The science of small clinical trials played an essential role: non-neurological endpoints, biomarker, and regulatory alignment are key factors in successful drug development for lysosomal storage disorders. Being able to treat brain disease is the next frontier. This review is dedicated to the memory of Roscoe O. Brady, an early pioneer in the research of lysosomal storage diseases. 
655 7 |a Festschrift  |0 (DE-588)4016928-5  |0 (DE-627)104400986  |0 (DE-576)208917802  |2 gnd-content 
700 1 |a Brady, Roscoe Owen  |d 1923-2016  |e GefeierteR  |0 (DE-588)1161631305  |0 (DE-627)1024925838  |0 (DE-576)50678455X  |4 hnr 
773 0 8 |i Enthalten in  |t Journal of inherited metabolic disease  |d Hoboken, NJ : Wiley, 1978  |g 40(2017), 3, Seite 343-356  |h Online-Ressource  |w (DE-627)320457753  |w (DE-600)2006875-X  |w (DE-576)105704652  |x 1573-2665  |7 nnas  |a Enzyme replacement therapy and beyond in memoriam Roscoe O. Brady, M.D. (1923-2016) 
773 1 8 |g volume:40  |g year:2017  |g number:3  |g pages:343-356  |g extent:14  |a Enzyme replacement therapy and beyond in memoriam Roscoe O. Brady, M.D. (1923-2016) 
856 4 0 |u http://dx.doi.org/10.1007/s10545-017-0032-8  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s10545-017-0032-8  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180622 
993 |a Article 
994 |a 2017 
998 |g 136385338  |a Ries, Markus  |m 136385338:Ries, Markus  |d 910000  |d 910500  |e 910000PR136385338  |e 910500PR136385338  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j  |y j 
999 |a KXP-PPN1576784703  |e 3013448733 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"17 March 2017","dateIssuedKey":"2017"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"id":{"zdb":["2006875-X"],"doi":["10.1002/(ISSN)1573-2665"],"eki":["320457753"],"issn":["1573-2665"]},"title":[{"title_sort":"Journal of inherited metabolic disease","title":"Journal of inherited metabolic disease","subtitle":"JIMD ; official journal of the Society for the Study of Inborn Errors of Metabolism"}],"note":["Gesehen am 11.03.20","Ungezählte Beil.: Suppl"],"disp":"Enzyme replacement therapy and beyond in memoriam Roscoe O. Brady, M.D. (1923-2016)Journal of inherited metabolic disease","language":["eng"],"origin":[{"publisher":"Wiley ; Kluwer ; Springer Science + Business Media B.V","dateIssuedDisp":"1978-","publisherPlace":"Hoboken, NJ ; Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedKey":"1978"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"40(2017), 3, Seite 343-356","volume":"40","issue":"3","year":"2017","extent":"14","pages":"343-356"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320457753","pubHistory":["1.1978 -"],"titleAlt":[{"title":"JIMD"}]}],"person":[{"roleDisplay":"VerfasserIn","family":"Ries","display":"Ries, Markus","role":"aut","given":"Markus"},{"family":"Brady","roleDisplay":"GefeierteR","given":"Roscoe Owen","role":"hnr","display":"Brady, Roscoe Owen"}],"physDesc":[{"extent":"14 S."}],"name":{"displayForm":["Markus Ries"]},"note":["First online: 17 March 2017","Gesehen am 22.06.2018"],"recId":"1576784703","title":[{"title_sort":"Enzyme replacement therapy and beyond","title":"Enzyme replacement therapy and beyond","subtitle":"in memoriam Roscoe O. Brady, M.D. (1923-2016)"}],"id":{"eki":["1576784703"],"doi":["10.1007/s10545-017-0032-8"]}} 
SRT |a RIESMARKUSENZYMEREPL1720